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Abstract
 
Serum antibody (Ab) can play several roles during B cell immune responses. Among these is to
promote the deposition of immune complexes (ICs) on follicular dendritic cells (FDCs). ICs on
FDCs are generally thought to be critical for normal germinal center (GC) formation and the
development and selection of memory B cells. However, it has been very difficult to test these
ideas. To determine directly whether FDC-bound complexes do indeed function in these
roles, we have developed a transgenic (Tg) mouse in which all B lymphocytes produce only
the membrane-bound form of immunoglobulin M. Immune Tg mice have 10,000-fold less
specific Ab than wild-type mice and lack detectable ICs on FDCs. Nonetheless, primary im-
mune responses and the GC reaction in these mice are robust, suggesting that ICs on FDCs do
not play critical roles in immune response initiation and GC formation. Moreover, as indicated
by the presence and pattern of somatic mutations, memory cell formation and selection appear
normal in these IC-deficient GCs.
Key words: B lymphocyte • transgenic mouse • surface immunoglobulin • lambda light chain • 
immunological memory
 
Introduction
 
Immune responses in the spleen begin with proliferating B
and T cells at the interface of the T and B cell zones (1, 2).
Within a few days, early Ab-forming cells (AFCs)
 
1
 
 are seen,
which provide the first sources of serum Ab. The B cells
that participate in the early extrafollicular reaction are gen-
erally of low affinity (3). By day 6 after immunization, the
first signs of the germinal center (GC) reaction are evident.
Over the next 10 d, the GC reaction peaks, culminating in
the selection of higher affinity mutants and the differentia-
tion of both memory cells and plasma cells.
 
Follicular dendritic cells (FDCs) are thought to play a
key role in the formation of GCs, as well as in selection,
differentiation, and maintenance of memory B cells. FDCs
are dendritiform, nonphagocytic cells found in the follicles
of secondary lymphoid organs (4). A striking characteristic
of FDCs is their ability to retain native immune complexes
(ICs) on their surface for long periods of time (5). The
half-life of radiolabeled Ags on FDCs is months, if not
years (6). Complement receptors (CRs) provide the main
mechanism for ICs trapping on FDCs. C3 fragments
bound to ICs bind CR1 (CD35) and CR2 (CD21), which
are highly expressed on FDCs (7, 8). Depletion of C3 by
cobra venom factor inhibits Ag localization to FDCs (9), as
does treatment with anti-C3 (10) or anti-CR1/2 (11). ICs
also bind Fc receptors on FDCs, particularly during the
GC response (11). Hence, except for certain Ags that
might fix sufficient complement autonomously, both
mechanisms for Ag retention by FDCs require that Ag be
complexed with Ab.
Several important functions have been postulated for the
ICs that deposit on FDCs. It has been hypothesized that
the initial localization of ICs on FDCs nucleates the GC re-
sponse and provides the Ag to which GC B cells respond
(6, 12). This idea provides an explanation for the delayed
appearance of GCs, since several days would be needed to
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provide the Ab required to allow ICs to form and deposit.
Not all earlier data agree with this role of IC deposition on
FDCs. Kroese et al. reported that rats which are reconsti-
tuted with mature lymphocytes after irradiation can make
early GC responses to SRBC immunization even though
their FDCs are transiently impaired in IC trapping at the
time GCs are first observed (13). ICs on FDCs have also
been suggested to provide the stimulus that rescues centro-
cytes from apoptosis (14), thus leading to the formation of
memory B cells. The initiation of somatic mutation, which
normally occurs in the GC, may also depend on encounter
with Ag on the FDCs. Competition with previously
formed Ab for Ag sequestered in ICs on FDCs is thought
to drive affinity maturation of B cells (15). Thus, ICs are
thought to drive the initiation and normal progression of
GC and memory cell development.
Although these proposed roles for ICs retained on FDCs
fit with various correlative data, they have been difficult to
evaluate experimentally. Mice that lack TNFR family re-
ceptors or ligands lack FDCs and also generally lack GCs.
The study of immune responses in these animals has been
used to draw conclusions about the roles of FDCs (16, 17).
Although there are clearly some memory formation defects
in these mice, the interpretation of these data is compli-
cated. It is difficult to attribute the mechanism of immune
response defects because these mice have markedly disorga-
nized lymphoid architecture, as well as carry mutations in
key cytokine or chemokine pathways (18–20) that may
have direct effects on lymphocyte responses. Moreover,
studies in these mutant strains do not distinguish between
the role of FDC-bound ICs and other essential functions of
the FDCs since neither are present.
An additional informative approach has been the study
of mice that lack CR1/2, in which the FDC’s ability to
capture Ag is reduced. These mice make very weak Ab re-
sponses to T cell–dependent Ags, as well as reduced GC re-
sponses (21, 22). However, at least a substantial part of the
deficiency was due to disruption of CR1/2 expression on
B cells, and not primarily due to FDCs lacking the ability
to capture ICs via CR1/2 (21, 23). In any case, Ag may
deposit on FDCs via Fc receptors even in the absence of
the CR1/2 receptor (11).
To better define the roles of ICs on FDCs, it would be
advantageous to study B cell immune responses in the ab-
sence of secreted Ab and hence in the absence of IC depo-
sition on FDCs. To accomplish this, we have developed a
transgenic (Tg) mouse in which B cells are functional but
cannot secrete Ab. The membrane Ig (mIg) Tg consists of a
rearranged VDJ joined to an IgM H chain from which the
secreted exon and polyadenylation site had been excised
(24). We chose to use Vh186.2 so that pairing of the Tg H
chain with endogenous 
 
l
 
 light chain would result in a
small, readily detectable population of cells specific for the
hapten (4-hydroxy -3-nitrophenyl)acetyl (NP). As mIg Tg
mice have markedly reduced Ab and undetectable IC dep-
osition on FDCs, we have used them to investigate the role
of Abs in the development and maintenance of primary and
secondary immune responses.
 
Materials and Methods
 
mIg Construct and Tg Mouse Production.
 
The mIg H chain
construct was as described (24). In brief, a rearranged VDJ seg-
ment containing Vh186.2 was ligated to an IgM
 
a
 
 constant region
from which the secreted exon and polyadenylation site had been
excised, resulting in production of only membrane-bound Ig.
The construct was tested by transfection into CH1, a 
 
l
 
/IgM
 
b
 
-ex-
pressing cell line (25). CH1-mIg transfectants expressed surface
IgM
 
a
 
 anti-NP, yet did not secrete any detectable IgM
 
a
 
 into cul-
ture supernatant (data not shown). A control strain, the mem-
brane plus secreted Ig ([m
 
1
 
s]Ig) Tg, was produced using a similar
construct with an intact secreted exon.
Tg-positive founders were identified by Southern blot. mIg
Tg mice were first backcrossed with CB.17 mice (IgM
 
b
 
 congen-
ics of BALB/c). Levels of Tg-derived surface IgM
 
a
 
 expression on
B cells from the founder lines were compared with the (m
 
1
 
s)Ig
control strain by FACS
 
®
 
; two that matched the (m
 
1
 
s)Ig Tg mice
closely were chosen for study. To eliminate endogenous H chain
production, the mIg Tg 
 
3
 
 CB.17 mice were backcrossed onto
the J
 
H
 
 knockout strain (J
 
H
 
D/CB.17). The resulting strain, re-
ferred to as mIg Tg, has 
 
.
 
99% CB.17 background genes. mIg Tg
mice are housed under specific pathogen-free conditions and re-
ceive Sulfatrim in drinking water 4 d/wk.
 
Ags and Immunizations.
 
Chicken gamma globulin (CGG;
Sigma-Aldrich) and human serum albumin (HSA; Amour Phar-
maceutical) were haptenated with NP-hydroxysuccinimide ester
(Cambridge Research Biochemicals/Genosys). 7–12-wk-old mice
were immunized intraperitoneally with 50 
 
m
 
g alum-precipitated
NP
 
24
 
CGG or NP
 
15
 
HSA. For secondary immunizations, 50 
 
m
 
g sol-
uble Ag was administered in PBS.
 
ELISA.
 
Anti-NP was measured as 
 
l
 
1
 
 Ig that binds to (4-
hydroxy-3-nitro-2-iodo-phenyl)acetyl (NIP)-BSA–coated plates.
In the context of the Vh186.2 Tg, this should account for virtu-
ally all anti-NP, and includes all Ig H chain isotypes. Immulon 2
plates (Dynex Technologies) were coated overnight with NIP
 
26
 
-
BSA. Plates were blocked with 1% BSA, followed by incubation
with serial dilutions of serum at 37
 
8
 
C for 1 h. After washing and
incubation with polyclonal anti-
 
l
 
–alkaline phosphatase (South-
ern Biotechnology Associates, Inc.) plates were developed with
 
p
 
-nitrophenyl phosphate (Sigma-Aldrich). For anti-IgM ELISA,
plates were coated overnight with b7-6 (anti-IgM) and blocked
with 1% BSA; anti-IgM–alkaline phosphatase (Southern Biotech-
nology Associates, Inc.) was used as the secondary Ab.
 
Flow Cytometry.
 
FACS
 
®
 
 was performed as described (26). PE
(Molecular Probes) haptenated with NIP-hydroxysuccinimide
ester (NIP-PE; Cambridge Research Biochemicals/Genosys) was
used to identify NP-specific B cells, as Vh186.2/
 
l
 
 recognizes
NIP with high affinity. In addition to NIP-PE, splenocytes were
stained with anti-
 
l
 
–fluorescein (Southern Biotechnology Associ-
ates, Inc.), and GL-1–biotin (anti–B7-2) followed by streptavi-
din–Spectral red (Southern Biotechnology Associates, Inc.).
 
Histology.
 
5 
 
m
 
m frozen spleen sections were thaw mounted
onto poly-
 
l
 
-lysine (Sigma-Aldrich)–coated slides, fixed in cold
acetone for 10 min, and stored at 
 
2
 
80
 
8
 
C. Tissue was blocked
with 1% BSA (Gemini Bioproducts) in PBS/0.1% Tween 20, or
with 1% ovalbumin (ICN Biomedicals) containing 10% rat serum
(Gemini Bioproducts) when staining with mouse anti-HSA. Sec-
tions were stained with peanut agglutinin–horseradish peroxidase
(PNA-HRP; EY Labs), anti-
 
l
 
–alkaline phosphatase (Southern
Biotechnology Associates, Inc.), anti-CD35–biotin (BD Phar-
Mingen), anti-CGG–biotin (Accurate), or anti-HSA–biotin. Anti-
HSA was affinity purified from serum of HSA-immune BALB/c
mice; serum was complement inactivated at 56
 
8
 
C for 30 min, di- 
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luted 1:1 with PBS containing 0.05% sodium azide, and run over
a column of HSA-coupled Affi-Gel 15 (Bio-Rad Laboratories).
Eluted anti-HSA was then conjugated to biotin-XX (Molecular
Probes).
 
In Vitro Deposition of ICs.
 
Goat anti-CGG (Southern Bio-
technology Associates, Inc.) and CGG protein were mixed to-
gether at a weight ratio of 2:1 with fresh 10% mouse serum in
PBS on ice for 30 min to form ICs at the dilutions indicated. ICs
were incubated at 37
 
8
 
C for 1 h on acetone-fixed sections of
spleen from an mIg Tg mouse that had received 50 
 
m
 
g NP-CGG
in alum 12 d earlier. The deposited complexes were detected
with a biotinylated donkey F(ab
 
9
 
)
 
2
 
 anti-CGG Ab (Accurate) and
developed with streptavidin–alkaline phosphatase reagent. The in
vivo–localized Ag was developed at the same time in both the
mIg Tg mouse (same mouse as used for the in vitro localization)
and the day 9 immune (m
 
1
 
s)Ig Tg mouse for negative and posi-
tive controls, respectively, using the same detection Ab and sub-
strate.
 
Sequencing.
 
l
 
1
 
 day 16 GCs were microdissected from stained
spleen sections. Cell clusters were digested overnight at 37
 
8
 
C in
20 
 
m
 
l 25% PBS containing 10 
 
m
 
g proteinase K. V
 
l
 
1 sequences
were amplified by nested PCR using Pfu (Stratagene): external
primers 5
 
9
 
-GCACCTCAAGTCTTGGAGAG-3
 
9
 
 and 5
 
9
 
-ACT-
CTCTCTCCTGGCTCTCA-3
 
9
 
, and internal primers 5
 
9
 
-CTA-
CACTGCAGTGGGTATGCAACAATGCG-3
 
9
 
 and 5
 
9
 
-GTT-
CTCTAGACCTAGGACAGTCAGTTTGG-3
 
9
 
. Amplified DNA
was isolated by phenol/chloroform/isoamyl alcohol (25:24:1) ex-
traction followed by gel purification, digestion of gel blocks with
GELase (Epicentre), and ethanol precipitation. V
 
l
 
1 DNA was li-
gated via T4 DNA ligase (New England Biolabs, Inc.) to pBlue-
script II KS (Stratagene) cut with PstI and XbaI (New England
Biolabs, Inc.). Ligation products were transformed into DH5
 
a
 
.
V
 
l
 
1 DNA was further amplified by placing colonies directly into
PCR reactions containing the following primers: 5
 
9
 
-AATTAA-
CCCTCACTAAAGGG-3
 
9
 
 and 5
 
9
 
-GTAATACGACTCACT-
ATAGGGC-3
 
9
 
. DNA was purified from the PCR reaction mix-
ture with GFX DNA and Gel Band Purification kit (Amersham
Pharmacia Biotech), mixed with sequencing primer 5
 
9
 
-TCGAG-
GTCGACGGTATC-3
 
9
 
, and sequenced by the Keck Biotech-
nology Resource Laboratory at Yale University School of Medi-
cine using Applied Biosystems 377 DNA sequencers.
 
Statistics.
 
The unpaired 
 
t
 
 test was performed using StatView
v4.5 (Abacus Software).
 
 P 
 
, 
 
0.05 was considered significant.
 
Results
 
The mIg Tg Reconstitutes NP Binding by
 
 l
 
1
 
 B Cells but
without Detectable Anti-NP Ab.
 
The mIg Tg has been
backcrossed onto the J
 
h
 
 knockout strain (J
 
h
 
D/J
 
h
 
D), and
thus only the Tg-encoded H chain V region is expressed.
As predicted, expression of Vh186.2 in all B cells yields 2–4%
of splenocytes in an unimmunized mIg Tg mouse that are
NP specific and 
 
l
 
1
 
 by FACS
 
®
 
 analysis (Fig. 1). The control
(m
 
1
 
s)Ig Tg strain, made from an otherwise identical con-
struct that retains the intact secreted exon, has a similar
NP-specific population. To confirm that mIg Tg B cells
were not capable of secreting IgM upon stimulation in
vitro, mIg Tg splenocytes were cultured for 5 d with 50
 
m
 
g/ml LPS (Fig. 2). As expected, mIg Tg splenocytes did
not produce any detectable IgM. Splenocytes from mIg Tg
mice with intact endogenous Ig Jh alleles did produce IgM,
presumably emanating from a small number of B cells that
expressed endogenous H chains.
No NP-specific Ig could be detected in sera from naive
mIg Tg mice, even with an assay sensitivity of 20 ng/ml;
indeed, mIg Tg sera were indistinguishable from J
 
h
 
D/J
 
h
 
D
control sera (data not shown). Anti-NP concentrations in
unimmunized (m
 
1
 
s)Ig Tg and CB.17 mice were in the
range of 1 
 
m
 
g/ml.
 
mIg Tg Mice Mount Primary Responses.
 
Having eliminated
preexisting Ab, we asked whether mIg Tg mice would de-
velop a normal primary response, since ICs might be im-
portant in the initial stimulation of B cells (27, 28). To de-
termine if primary responses in mice with similar B cell
Figure 1. The mIgM Tg rescues B cell development and confers spec-
ificity for NIP on l1 B cells when expressed on the JhD background.
FACS® profiles of splenocytes from CB.17 (left) or mIg Tg mice (JhD
background) are shown. The top row demonstrates sole expression of
IgMa in the mIg Tg mice. The bottom row demonstrates that l1 B cells
in the mIg Tg mice bind to NIP (as NIP-PE) in proportion to the
amount of surface l. There are practically no detectable l1 NP-binding
cells in the CB.17 mice (bottom left).
Figure 2. Lack of secretion of
IgM from mIg Tg mice after
stimulation by LPS in vitro.
Splenocytes from mIg Tg mice
(i.e., on the JHD background)
and the original mIg 3 CB.17
mice (which expressed some en-
dogenous H chain) were cul-
tured with 50 mg/ml LPS for 5 d
to determine their capacity to
secrete IgM in vitro. Superna-
tants from multiple wells were
pooled and total IgM was quan-
titated by ELISA. 
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repertoires would be diminished by lack of Ab, mIg Tg and
(m
 
1
 
s)Ig Tg mice were immunized with NP-HSA, NP-
CGG, or CGG alone, and splenocytes were analyzed by
FACS
 
®
 
 between days 0 and 28 (Fig. 3). Ag-specific B cells
bound NIP-PE and expressed 
 
l
 
 light chain (Fig. 1). In NP-
immunized mIg Tg and (m
 
1s)Ig Tg mice, Ag-specific B
cells comprised an increasingly large percentage of the sple-
nocytes (Fig. 3 A), peaking between days 12 and 16. Simi-
lar effects were seen on the total number of NP-specific
cells (data not shown). There is a similar proportional in-
crease of NP-specific cells in both strains. By day 28, the
percentage of NP-specific cells in both Tg strains had
dropped, although not yet back to baseline levels. NP-spe-
cific B cells in carrier-immunized controls remained near
baseline levels.
To provide evidence of Ag-specific activation of mIg Tg
B cells, we determined the percentage of NP-specific sple-
nocytes expressing high levels of B7-2 after immunization
with NP or carrier (Fig. 3 B). The percentage of B7-2high
NP-specific cells peaks at day 12 in both mIg Tg and
(m1s)Ig Tg mice, whereas levels in carrier-immunized
mice remain low. These results indicate that mIg Tg B cells
become activated upon immunization, with kinetics similar
to those of (m1s)Ig Tg controls.
Ab Levels in mIg Tg Serum Are Markedly Reduced. In spite
of robust proliferative responses that resulted in 15–20% of
total splenocytes carrying the NP specificity, serum Ab re-
sponses to immunization in mIg Tg mice were severely
blunted and required an ultrasensitive assay for detection.
At day 12 after immunization with NP-HSA, there was a
mean of 90 ng/ml anti-NP in mIg Tg sera; five of six mice
had #60 ng/ml (Fig. 4). This quantity of NP Ab is 100-
fold less than in immunized (m1s)Ig Tg mice and 10,000-
fold less than in immunized CB.17 mice, despite the much
higher precursor frequency of NP-specific B cells in mIg
Tg mice than in CB.17 mice.
It was surprising to find any serum Ab in mIg Tg mice
since endogenous Jh loci in these mice are inactivated.
Shedding of mIgM is unlikely to account for this, given
our inability to detect any secreted IgM in vitro after LPS
stimulation. Some of the Ab is IgG (data not shown), and
thus we believe that these minute quantities of Ab arise via
rare interchromosomal isotype switch events between the
Tg locus and the endogenous IgH loci (29). Regardless of
the mechanism by which this Ab emerges, the quantity of
anti-NP at day 12 after immunization in mIg Tg mice is
three orders of magnitude less than the amount of immu-
nizing Ag, whereas in CB.17 mice, Ab is far in excess of
Ag. This indicates that if any ICs form in the mIg Tg
model, the amount must be radically reduced. In particular,
the likelihood that two Ab molecules would bind Ag in
close proximity, as required for C9 activation, is remote
given the extreme Ag excess.
mIg Tg Mice Produce NP-specific GCs. The second ques-
tion addressed in these studies was whether GCs would
form in the absence of IC deposition. This question was
raised by the suggestion that early and/or preexisting Ab
Figure 3. Time course analysis of primary re-
sponse to NP immunization. mIg and (m1s)Ig Tg
splenocytes were analyzed by FACS® at various
time points after immunization with NP-HSA,
NP-CGG, or CGG alone. (A) Mean percentages of
NP-specific splenocytes; (B) the mean percentage
of NP-specific splenocytes that are B7-2high. Error
bars indicate SEM. Numbers of mice: d0, n 5 4;
d28, n 5 3; d5–16, NP-HSA, n 5 3; CGG mIg
Tg, n 5 4–5; NP-CGG mIg Tg, n 5 5–6; CGG
(m1s)Ig Tg, n 5 3; NP-CGG (m1s)Ig Tg, n 5 4–7.
Data are combined from three experiments.
Figure 4. Ab secretion is markedly reduced in mIg Tg mice. NP Ab
levels from mIg Tg, (m1s)Ig Tg, and CB.17 mice bled on day 12 after re-
ceiving 50 mg NP-HSA. Error bars indicate SEM. Note that mIg Tg mice
produce z10,000-fold less NP Ab compared with wild-type CB.17 mice.935 Hannum et al.
was required in order to promote the shift to the GC reac-
tion (12). If so, GC formation in mIg Tg mice—with no
preexisting anti-NP and a 4-log reduction in Ab at a time
when the GC response peaks—should be impaired. To in-
vestigate this, spleen sections from mIg Tg, (m1s)Ig Tg,
and CB.17 mice, removed on day 12 after immunization,
were double-stained with PNA and anti-l to identify l1
(NP-specific) GCs. mIg Tg mice produced NP-specific
GCs upon immunization with either NP-CGG or NP-
HSA; carrier-immunized mIg Tg mice produced only l2
(presumably carrier-specific) GCs (Figs. 5 and 6). The
number of NP-specific GCs present in the mIg Tg spleens
was equal to or greater than that in the (m1s)Ig Tg or
CB.17 spleens (Fig. 6), indicating that the mIg Tg GC re-
sponse is not diminished by lack of Ab or ICs. Indeed, as is
evident from the substantially greater size of the GCs in
both types of Tg mice compared with those in CB.17 mice
(Fig. 6), the Tg mice make extremely vigorous GCs.
Moreover, the kinetics of the GC response is similar in the
two types of Tg mice (data not shown). The normal GC
response in mIg Tg mice is not solely attributable to the
enriched anti-NP repertoire, as carrier Ags also induce GCs
despite the presumably below normal precursor frequencies
for the carrier epitopes (Fig. 5 B, Fig. 6, and data not
shown).
Lack of Detectable Ag Localization in mIg Tg Mice. To con-
firm that the marked reduction in specific Ab levels in mIg
Tg mice prevented normal localization of Ag to the FDCs,
adjacent spleen sections were stained with a polyclonal an-
tiserum specific for the protein Ag carrier or with mono-
clonal anti-CD35, along with PNA. This strategy identifies
Ag deposited on FDCs in GCs. A rigorous test of Ab-
mediated localization of Ag is secondary immunization, in
which case any leakiness in the system should be revealed.
5 wk after receiving 50 mg NP-CGG, mIg and (m1s)Ig Tg
mice were given 50 mg NP-CGG intravenously in PBS.
Spleens were removed at day 3 after reimmunization, and
serial spleen sections were stained. There was no detectable
localization of Ag in mIg Tg spleens, whereas numerous
FDC networks in (m1s)Ig Tg spleens stained darkly with
anti-CGG (Fig. 7, A–D). Similar results were achieved
when mIg and (m1s)Ig Tg mice were reimmunized with
NP-HSA 12 wk after primary immunization and spleen
sections were stained with anti-HSA (Fig. 7, E–H). Note
Figure 5. mIg Tg mice produce GCs.
Spleens from mIg Tg, (m1s)Ig Tg, and
CB.17 mice were removed on day 12 after
immunization with NP-CGG or CGG.
Spleen sections were stained with PNA-
HRP (red) to detect GCs and anti-l light
chain (blue) to detect l-expressing B cells.
Immunization with NP-CGG produces l1
NP-specific GCs: (A) mIg Tg, (C) (m1s)Ig
Tg, (D) CB.17. Immunization with CGG
produces only l2 GCs (B; mIg Tg). Note
the much larger size of the GCs from mIg
Tg and (m1s)Ig Tg mice (A–C) compared
with wild-type mice (D).
Figure 6. mIg Tg mice make a normal number of GCs in response to
immunization. The mean number of NP-specific GCs per random 403
view of spleen sections; error bars indicate SEM. Means represent counts
from three to eight mice per treatment group. Bar heights show total
number of GCs. The number of l1 GCs is indicated by the hatched bars
and the number of l2 GCs by the gray bars. unim, unimmunized.936 Germinal Center Formation in the Absence of Antibody
from the serial sections stained with anti-CR1/2 to reveal
FDCs that the pattern of Ag deposition matched the distri-
bution of FDCs. We also investigated primary responses: as
expected from the secondary response data, at day 12 after
NP immunization, no Ag was detectable in mIg Tg mice,
whereas Ag was clearly visible in many (m1s)Ig Tg GCs
(Fig. 8 and data not shown).
The sensitivity of detection was investigated using an in
vitro IC-localization assay to construct a standard curve for
comparison with simultaneous staining of in vivo samples
(see Materials and Methods). In vitro–prepared ICs using
CGG and a polyclonal anti-CGG were incubated in the
presence of fresh mouse serum with spleen sections from
day 12 immune mIg Tg mice. Since essentially all GCs in
mIg Tg mice are l1 and thus NP specific (see Fig. 6), there
should be few if any B cells in GCs of these immune mice
that could bind the carrier Ag CGG. Binding to FDCs was
detected using labeled anti-CGG, as performed for in vivo
Figure 7. Lack of Ag localization in mIg
Tg mice. Spleens were removed on day 3 or
5 after secondary immunization with NP-
CGG (A–D) or NP-HSA (E–H), respec-
tively, from either mIg Tg (A, B, E, and F)
or (m1s)Ig Tg (C, D, G, and H) mice. Se-
rial spleen sections were stained with PNA-
HRP to show GCs (red), plus anti-CGG (A
and C) or anti-HSA (E and G) to detect lo-
calized Ag (blue), and anti-CD35 (B, D, F,
and H) to visualize FDCs (blue). FDCs are
present in mIg Tg mice; however, no Ag
localization was detected in any mIg Tg
GCs. Original magnification: 340 (A–F)
and  3100 (G and H).937 Hannum et al.
Ag localization studies in Fig. 7. The quantities of ICs were
then titrated and an endpoint dilution was established (Fig.
8). The pattern of this distribution resembles that of FDCs,
as determined by staining with anti-CR1/2 on adjacent
sections (data not shown). Moreover, no such localization
was seen in the absence of a source of fresh C9 (data not
shown), again strongly indicating that deposition on FDCs,
rather than binding to B cells, is being observed. The dilu-
tion that gave similar intensity of staining to the in vivo lo-
calization that was detected simultaneously on sections
from (m1s)IgM Tg mice was identified. By comparing this
to the endpoint, a minimum estimate of the sensitivity was
obtained. We estimate this to be 400-fold less than the in-
tensity routinely seen in the (m1s)IgM Tg mice, thus at-
tributing an order of magnitude to the meaning of lack of
detectable ICs in the mIg mice.
mIg Tg GC B Cells Undergo Somatic Mutation of the Vl
Region. Somatic mutation of Ig genes is a hallmark of
memory B cells (30). Selection of mutations, presumably
based on higher affinity, occurs concurrent with memory B
cell development (31). In TNFR family knockout mice,
memory B cell development was abnormal. To determine
whether lack of ICs on FDCs affected memory B cell de-
velopment by altering mutation or selection in the mIg Tg
mice, we microdissected NP-specific GCs from spleen sec-
tions of mIg Tg and (m1s)Ig Tg mice at day 16 after im-
munization and sequenced the endogenous Vl1 genes.
Clearly, mutation is occurring in mIg Tg mice, with the
average Vl having 1.4 mutations in z300 basepairs se-
quenced. This frequency is comparable to the number of
Vh chain mutations in l1 GCs of normal mice (32). In
both mIg Tg and (m1s)Ig Tg mice, the numbers of re-
placement mutations in l CDRs are significantly higher
than would be predicted at random, suggesting that selec-
tion of mutants by Ag also takes place in mIg Tg GCs (Ta-
ble I). We compiled a list of partial sequences showing all
the Vl codons that contained replacement mutations in
any of the sequences from mIg Tg and (m1s)Ig Tg mice,
Figure 8. Estimation of the sensitivity of IC detection on FDCs in vivo. ICs that had been naturally deposited in vivo or artificially in vitro were de-
tected using the same reagents at the same time, as described in detail in Materials and Methods. Since mIg Tg mice are negative in the in vivo deposition
assay (B and see Fig. 7), we undertook this experiment to estimate the dynamic range of the assay and to establish the minimum amount of reduction
needed in the mIg Tg in order to have a negative result. Thus, a dilution series was constructed for the in vitro ICs, which were then assayed on serial
sections of mIg Tg spleen. All staining and development were performed simultaneously and stopped at the same time. A shows typical in vivo localiza-
tion in (m1s)Ig Tg mice. B shows the lack of such in a mIg Tg mouse. D–F show various dilutions of the IC titrations: (C) 20 mg/ml; (D) 2.5 mg/ml;
(E) 0.15 mg/ml; and (F) 0.05 mg/ml. The intensity of staining in C was comparable to the in vivo positive in A. At 400-fold less ICs (F), staining is barely
detectable in nearly all GCs (F; and other similar GCs not shown), indicating an endpoint for the titration. Thus, there is an z400-fold dynamic range of
the assay, and lack of staining roughly corresponds to a 400-fold or greater reduction in deposited ICs.
Table I. Number of Replacement (R) and Silent (S) Mutations in 
Vl1 Sequences from GC B Cells
FR CDR
Strain Ag n R S All R S All P value
mIg Tg NP-CGG 30 9 8 17 18 1 19 3.6 3 1022
mIg Tg NP-HSA 23 12 4 16 20 4 24 6.6 3 1026
(m1s)Ig Tg NP-CGG 16 16 1 17 23 2 25 ,1026
P values are shown for the difference in CDR replacement mutations
from expected frequencies. P values and the expected number of
replacement mutations for the Vl1 sequence were calculated using
programs by Chang and Casali (reference 51).938 Germinal Center Formation in the Absence of Antibody
plus those reported in NP-CGG–immunized C57BL/6
mice (33; Fig. 9). Several mutations seen in mIg Tg CDRs
are also seen in (m1s)Ig Tg and normal mice. These recur-
rent amino acid replacements are found almost exclusively
in the CDRs, again suggesting that Ag-driven selection is
occurring and that it is qualitatively comparable to that in
Ab-secreting mice.
Discussion
These studies test several long-held ideas about the role
of preexisting Ab and ICs in the normal development of B
cell immune responses. By providing a scenario in which B
cells exist in the near absence of Ab, the mIg Tg mouse
model allows us to distinguish between processes in which
ICs actually participate and those that simply coincide with
the presence of Ag on FDCs. The ability to make these dis-
tinctions without resorting to gene deletions that result in
pleiomorphic defects suggests a reevaluation of some of the
current concepts for the role of FDC-bound ICs in primary
B cell responses.
A 4-log reduction in specific Ab was achieved in the mIg
Tg mice. Consistent with this reduction, there was no de-
tectable deposition (.400-fold reduction) of Ag on FDCs
in vivo in mIg Tg mice. The lack of IC deposition con-
firmed the widely held concept that such deposits are Ab
dependent, with the ICs binding FcRs and CR1/2 (11) on
FDCs. Since Ag is deposited on FDCs as ICs, it seems
likely that for most Ags the process is dependent on the
classical pathway, an idea confirmed by our findings that
observable deposition required the presence of Ab both in
vivo and in vitro. In addition, immune responses are
grossly normal in Factor B–deficient mice (34), unlike the
situation for C4-deficient mice (35).
The proposed model we are testing is that the visible im-
mune deposits on FDCs are the limiting factor for GC de-
velopment, division, maturation, and memory B cell selec-
tion. Any process for which FDC-retained Ag is essential
should display inhibition at least proportional to the low-
ered Ab level. Were they not the limiting factor, the func-
tions attributed to these deposits in controlling the onset
and size of the GC and in providing limiting amounts of
Ag to promote affinity selection would not be possible. We
have eliminated the main if not the only mechanism of IC
deposition. According to the prevailing hypothesis, this
should have resulted in a detectable decrease in some or all
of these functions.
ICs were not required for a normal proliferative or GC
response, since GC reactions of normal size, frequency, and
kinetics were observed in mIg Tg mice. This is not simply
an effect of high anti-NP precursor frequency, as carrier
Ags alone also elicit a good GC response. Thus, our data
are consistent with the interpretations of Kroese et al., who
inferred that IC localization may not be necessary for the
early GC response by studying irradiated rats, which tran-
siently demonstrate poor IC trapping by FDCs yet initiate
GC responses a few days before detectable IC localization
returns after irradiation (13). Here we further show that IC
deposition is not required for normal kinetics and size of
the GC reaction, or for later events such as mutation and
selection.
Recently, Ehrenstein et al. (27) concluded that natural
IgM accelerates the primary Ab response, an interpretation
based on delayed IgG production in mutant mice that
lacked secreted IgM but that contained secreted IgG. Simi-
larly, Boes et al. (28) inferred that IgM-containing ICs
stimulate GC reactions, since the GC response was moder-
ately impaired in a similar mutant model. However, the
fact that the GC response in mIg Tg mice is not diminished
compared with (m1s)Ig Tg or CB.17 mice argues against
this interpretation. The muted immune responses may re-
flect dominant signaling through the inhibitory FcgRIIB
(36) in mice that contain only IgG and no IgM. No such
imbalance would have existed in mIg Tg mice.
Time course analysis of the relative size and activation
state of NP-specific B cell populations revealed similar ki-
netics for primary responses in mIg Tg and (m1s)Ig Tg
mice. Based on in vitro data, Liu et al. suggested that B cell
receptor (BCR) signaling, as a consequence of binding Ag
on FDCs, rescues centrocytes from apoptosis (14). If such
interactions were truly critical, then we should have ob-
served massive loss of centrocytes and thus much smaller
GCs. Instead, we see large GCs with normal kinetics and
well-developed light zones. Therefore, although interac-
Figure 9. Vl1 sequences from mIg Tg mice contain replacement (R) mutations common to (m1s)Ig Tg and nontransgenic mice. GC cells from mIg
Tg and (m1s)Ig Tg mice were microdissected on day 16 after immunization with NP-CGG or NP-HSA, and Vl1 sequenced. All mIg Tg and (m1s)Ig
Tg Vl1 codons containing replacement mutations in any of the sequences are listed, in addition to those reported in C57BL/6 mice after NP-CGG im-
munization by Taketani et al. (reference 50). The number of sequences represented is shown in parentheses; see Table I for additional details. Shaded col-
umns indicate codons at which mIg Tg sequences share mutations with (m1s)Ig Tg and/or published non-Tg sequences.939 Hannum et al.
tion with Ag may well be critical for the preservation of
centrocytes in the GC, the source of Ag need not be ICs
bound to FDCs.
The normal kinetics of the proliferative and GC re-
sponses in mIg mice also has implications for the mecha-
nisms for turning off primary responses. The termination of
the primary response has been attributed both to Ab-medi-
ated Ag clearance and to inhibitory signals mediated by
FcgR coligation with the BCR, as would occur when B
cells bind IgG-containing ICs (36). Since the kinetics of
GC appearance are normal in mIg Tg mice, other intrinsic,
non–Ab-dependent mechanisms must also be important in
dampening the immune response.
Once the GC reaction is established, GC B cells undergo
somatic mutation of Ig genes (37). In the normal spleen,
mutation appears restricted to GCs (32), although the stim-
ulus for onset of mutation remains unclear. Direct sequenc-
ing of Vl genes microdissected from GCs shows that mu-
tation occurs normally in mIg Tg GC B cells, indicating
that ICs on FDCs are not responsible for the initiation of
mutation, although other signals from FDCs may still play a
role. Affinity maturation is thought to involve preferential
expansion and/or survival of those GC B cells that acquire
affinity-enhancing mutations. It is thought that higher-affin-
ity mutants are selected by their ability to compete with Ab
already bound to Ag on FDCs. Analysis of mutations in
mIg Tg mice does not support this concept. The number
of replacement mutations in l1 sequences is higher than
would be predicted for a nonselected population. Further,
comparison of patterns of replacement mutations in mIg
Tg mice with (m1s)Ig Tg and non-Tg mice reveals muta-
tions common to the three strains at several sites in CDRs.
Both of these features indicate that Ag-driven selection is
occurring in mIg Tg mice.
It is important to compare our findings with those of ei-
ther CR1/2 knockout or TNF/TNFR family knockout
mice. GCs developed normally in CR1/22/2 mice that
were provided with wild-type bone marrow, in which
only the FDCs lacked CR1/2 (21). However, a firm con-
clusion about IC localization was not drawn, since IC dep-
osition could still occur via FcRs (11). Moreover, a second
group found reduced GC formation when FDCs lacked
CR1/2, suggesting a role of CR1/2 on FDCs (38). Thus,
previous results in this area were conflicting with regard to
the role of IC localization and GC initiation. The finding
in mIg Tg mice that vigorous GC formation does occur in
the absence of deposition of ICs on FDCs establishes that
this event is not essential for GC formation.
The situation is also complex in TNF/TNFR family
knockouts. Affinity maturation and somatic hypermutation
have been reported in lymphotoxin (LT)-a2/2 mice,
which lack FDCs, have abnormal splenic architecture, and
do not form GCs (19). However, this response is subopti-
mal, requires high dose Ag or multiple immunizations, and
for some Ags such as SRBCs, IgG responses and memory
formation are dramatically reduced (16, 19). A similar pic-
ture was seen in the LT-b 2/2 mice (20). TNFR12/2 mice
can form long-lived memory cells if infected with replicat-
ing virus, but respond poorly and lack long-lived IgG or
memory if immunized with killed virus (17). However,
given the pleiotropic defects including lymphoid architec-
ture disruption consequent to lack of LT-a or TNFR1 ex-
pression throughout the body, it is difficult to draw specific
conclusions about the physiologic role of IC deposition on
FDCs from the LT-a or TNFR1 knockouts. The lack of
defects in follicular architecture and other functions of
FDCs in mIg Tg mice contrasts with the situation in LT-
deficient or TNFR12/2 mice, thus implicating disruptions
in these aspects, rather than lack of FDC-bound Ag, in the
immune response defects. Recent work from Chaplin and
colleagues highlights this point, demonstrating that the
normal lymphoid architecture is required to allow wild-
type memory B cells to function (16). mIg Tg mice have
apparently normal mutation and selection; mutation and
possibly some selection were also observed in the LT-defi-
cient mice, suggesting that GCs were not required for this
function. Thus GCs, but not FDC-bound ICs, are needed
for optimal mutation and selection, though the GCs are
not required for some degree of mutation.
It has been suggested that B cell CR1/2 cross-linking by
C3 fragments fixed on ICs was essential for B cell activa-
tion (35, 39, 40). If this were true, the normal activation
and expansion of NP-specific B cells in mIg Tg mice
would be surprising. There are at least two possible expla-
nations for this paradox: complement-complexed Ag is be-
lieved to augment B cell stimulation at particularly low
doses of Ag; the dose of the Ag (50 mg) used in our case,
though comparable to that used in the above studies, may
not have been limiting. However, even at 1/4 of this dose
per mouse we saw normal responses (data not shown). This
suggests that CR1/2 must by itself be present on a re-
sponding B cell for it to participate effectively in a GC re-
action, even if its BCR is strongly cross-linked. An addi-
tional possibility is that mIgM that is aggregated on the cell
surface by BCR ligation can fix complement (41, 42), and
that C3b deposition occurs locally at the surface of the B
cell. If this were the case, then the immune responses in
mIg Tg mice suggest that such a mechanism is sufficient to
drive B cell activation via CR1/2 and sIg cocross-linking.
The results reported here raise two general questions.
First, if Ag bound to FDCs is not required to promote the
primary GC reaction, what is the source of Ag to drive the
GC response? Second, what is the function of retained Ag
on FDCs if GC formation, mutation, and selection and
memory B cell development can occur in its absence? As
for the source of Ag, we do believe there must be a contin-
uous source to maintain the response. Normally, this
would be in the form of a proliferating pathogen that
would supply a fresh source until the pathogen was elimi-
nated. In the case of protein Ags, it is noteworthy that opti-
mal immunization requires a depot preparation as in alum
or Freund’s adjuvant. These depots would release a contin-
uous supply of Ags in a way that simulates the pathogen sit-
uation. In either case, there would be free Ag in the ani-
mal, which we believe is the normal source of Ag for B
cells. This should not be surprising, as free Ag is almost cer-940 Germinal Center Formation in the Absence of Antibody
tainly the source that initiates the extrafollicular as well as T
cell–independent responses. An additional interesting possi-
bility is marginal zone (MZ) B cells, which have been
shown to transport Ag into follicles (13, 43). However, in
mIg Tg mice FDCs are not evidently receptors of Ag trans-
ported via MZ B cells. Perhaps Ig secretion by MZ B cells
is an important aspect of their ability to transfer ICs to
FDCs. On the other hand, MZ B cells could well serve to
transport Ag directly to GC B cells in mIg Tg and possibly
normal mice. Given the results of Kroese et al. (13), this is
unlikely to be important for initiation of GCs but it could
be critical for the maintenance of GCs. Indeed, MacLennan
and colleagues have recently shown that there can be a GC
response that is T cell independent but not sustained, sug-
gesting that requirements for initiation and maintenance of
GCs are likely to be different (44). Finally, we cannot for-
mally exclude the possibility that alterations in Ag metabo-
lism in Ab-free mice could affect Ag distribution and at
least partially compensate for the lack of ICs bound to
FDCs. However, the unaltered kinetics of the GC response
in mIg Tg mice suggests that Ag availability is not markedly
altered. Nor did we detect an increase in B cell–bound Ag
(which was not readily observed in any situation, Figs. 5
and 8) in these mice.
Regarding the functions of FDC-bound Ag, there are
several possibilities. Although it is apparent from mutation
analysis that some selection does occur, we have not ruled
out impairment in mIg Tg mice. Long-term maintenance
of memory B cells remains an additional possible function
of retained Ag. Quantitation of memory B cells would help
resolve this, as would very long-term functional memory
experiments. FDCs could act as an IC “sink” for the GC
(45). By trapping any ICs present in the GC, FDCs would
reduce potential FcgR-mediated downregulation of acti-
vated GC B cells. The mIg Tg mouse is neutral in this re-
gard, as there are no ICs to be removed or to mediate
downregulation. An additional possibility is that retained
Ag could play a role in the regulation of Ab production, for
example by helping to promote plasma cell longevity. Re-
cent studies have revealed a population of long-lived
plasma cells in the bone marrow and spleen that continue
to undergo affinity maturation after the GC reaction has
waned (46, 47). Addition of IgG-complexed neutralized
Ag after primary immunization increased long-term spe-
cific Ab titers, suggesting a connection between the pres-
ence of retained Ag and continuing Ab production (48).
Interestingly, AFC survival in TNFR2/2 mice is much
more strongly impaired than memory cell survival (17).
These data are also consistent with the idea that, as Ab lev-
els wane, ICs on FDCs could dissociate, releasing some
bound Ag and thereby stimulating plasma cells to renew Ab
production.
The FDC network is a prominent and dynamic feature
of the B cell follicle and GC. The deposition and retention
of ICs on FDCs are striking and no doubt important as-
pects of FDC function. Our results suggest that the prevail-
ing concepts of how ICs contribute to the development,
selection, and possibly maintenance of memory B cells
should be reconsidered. More detailed evaluation will be
needed to further clarify the roles of IC capture and FDCs
in general. The system we describe here, along with others
such as the CR1/22/2 (21, 22) and FcR2/2 (49), should be
instrumental in this effort.
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